Urteste S.A. (URT.WA)
PLN 92.8
(-1.28%)
PLN 92.8
(-1.28%)
| Year | Eps | Eps Growth |
|---|---|---|
| 2023 | -4.32 PLN | -20.67% |
| 2022 | -3.58 PLN | -61.99% |
| 2021 | -2.21 PLN | -148.31% |
| 2020 | -0.89 PLN | -45.9% |
| 2019 | -0.61 PLN | 0.0% |
| Year | Eps | Eps Growth |
|---|---|---|
| 2024 Q1 | -0.94 PLN | -18.99% |
| 2024 Q2 | -0.39 PLN | 57.45% |
| 2023 Q4 | -0.79 PLN | 13.19% |
| 2023 Q1 | -1.25 PLN | -25.0% |
| 2023 Q2 | -1.47 PLN | -17.6% |
| 2023 Q3 | -0.91 PLN | 38.1% |
| 2023 FY | - PLN | -20.67% |
| 2022 Q1 | -0.86 PLN | -30.3% |
| 2022 FY | - PLN | -61.99% |
| 2022 Q4 | -1.00 PLN | -56.25% |
| 2022 Q3 | -0.64 PLN | 37.86% |
| 2022 Q2 | -1.03 PLN | -19.77% |
| 2021 Q4 | -0.66 PLN | -13.79% |
| 2021 Q3 | -0.58 PLN | -141.67% |
| 2021 Q2 | -0.24 PLN | 56.36% |
| 2021 Q1 | -0.55 PLN | 0.0% |
| 2021 FY | - PLN | -148.31% |
| 2020 Q2 | -0.21 PLN | 0.0% |
| 2020 FY | - PLN | -45.9% |
| 2019 FY | - PLN | 0.0% |
| Name | Eps | Eps Difference |
|---|---|---|
| Bioceltix S.A. | -3.49 PLN | -23.782% |
| BIOTON S.A. | 0.03 PLN | 16401.887% |
| Captor Therapeutics Spolka Akcyjna | -15.19 PLN | 71.56% |
| Mabion S.A. | 2.55 PLN | 269.412% |
| Molecure S.A. | -1.09 PLN | -296.33% |
| NanoGroup S.A. | -0.39 PLN | -1007.692% |
| Pharmena S.A. | 2.60 PLN | 266.154% |
| Poltreg S.A. | -2.91 PLN | -48.454% |
| Pure Biologics Spólka Akcyjna | -11.19 PLN | 61.394% |
| Ryvu Therapeutics S.A. | -4.02 PLN | -7.463% |
| Synthaverse S.A. | 0.07 PLN | 6481.093% |